{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-122149","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2024-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.746061+00:00","generated_at":"2026-05-29T19:33:27.682267+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Traws Pharma receives Nasdaq delisting notice for equity-rule non-compliance","bullets":["Nasdaq Staff notified Company on Nov 20, 2024 of non-compliance with $2.5M stockholders' equity requirement (Listing Rule 5550(b)(1)).","Company self-reported equity shortfall and requested Nov 14 hearing solely on equity rule; bid-price compliance was regained on Oct 29.","Awaiting determination from Nasdaq Hearings Panel; delisting remains a risk if plan not accepted.","Previously disclosed bid-price non-compliance resolved by 10 consecutive closing bids above $1.00/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-122149","json":"https://secwatch.observer/filing/0001104659-24-122149.json","markdown":"https://secwatch.observer/filing/0001104659-24-122149.md","text":"https://secwatch.observer/filing/0001104659-24-122149.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/0001104659-24-122149-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924122149/tm2429248d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T19:33:27.682267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}